Yeong-Chan Kim , Dong Hyun Kang , Kanghyun Choi , Yeon-Jin Yoo , Hyun Jin Kim , Si-Sun Choi , Seung-Hoon Kang , Eung-Soo Kim
{"title":"Splint-free circular RNA synthesis via RNA secondary structure–guided ligation","authors":"Yeong-Chan Kim , Dong Hyun Kang , Kanghyun Choi , Yeon-Jin Yoo , Hyun Jin Kim , Si-Sun Choi , Seung-Hoon Kang , Eung-Soo Kim","doi":"10.1016/j.nbt.2025.12.004","DOIUrl":null,"url":null,"abstract":"<div><div>Circular RNA (circRNA) is a covalently closed RNA molecule in which the 5′ and 3′ ends are joined. CircRNAs can be generated via RNA circularization, a process that links the termini of linear RNA. The most common <em>in vitro</em> method for RNA circularization is the ribozyme-based permuted introns and exons (PIE) system. However, circRNAs produced by the PIE method retain partial exogenous exon sequences, potentially leading to immunogenicity issues. In this study, we developed an alternative approach that exploits the secondary structure of linear RNA and enzymatic ligation to synthesize circRNA <em>in vitro</em> for targeted gene expression. We first predicted RNA secondary structures and designed linear RNA molecules to form a terminal nick structure. Using T4 RNA ligase 2 (T4 Rnl2), we sealed the nick to connect the RNA ends. This ligase-mediated <em>in vitro</em> circularization achieved high efficiency and enabled functional expression of the encoded target gene. While ligase-based splint-free circularization has been described for small RNA circles, reports demonstrating functional protein expression from such constructs remain limited. This ligase-mediated RNA circularization approach should be an efficient alternative for production of circular RNA. This ligase-mediated, secondary-structure–guided, splint-free strategy using T4 RNA ligase 2 represents an efficient alternative for circRNA production, enabling both high-yield synthesis and validated gene expression in mammalian cells.</div></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":"91 ","pages":"Pages 120-126"},"PeriodicalIF":5.6000,"publicationDate":"2026-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871678425001311","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Circular RNA (circRNA) is a covalently closed RNA molecule in which the 5′ and 3′ ends are joined. CircRNAs can be generated via RNA circularization, a process that links the termini of linear RNA. The most common in vitro method for RNA circularization is the ribozyme-based permuted introns and exons (PIE) system. However, circRNAs produced by the PIE method retain partial exogenous exon sequences, potentially leading to immunogenicity issues. In this study, we developed an alternative approach that exploits the secondary structure of linear RNA and enzymatic ligation to synthesize circRNA in vitro for targeted gene expression. We first predicted RNA secondary structures and designed linear RNA molecules to form a terminal nick structure. Using T4 RNA ligase 2 (T4 Rnl2), we sealed the nick to connect the RNA ends. This ligase-mediated in vitro circularization achieved high efficiency and enabled functional expression of the encoded target gene. While ligase-based splint-free circularization has been described for small RNA circles, reports demonstrating functional protein expression from such constructs remain limited. This ligase-mediated RNA circularization approach should be an efficient alternative for production of circular RNA. This ligase-mediated, secondary-structure–guided, splint-free strategy using T4 RNA ligase 2 represents an efficient alternative for circRNA production, enabling both high-yield synthesis and validated gene expression in mammalian cells.
期刊介绍:
New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international.
The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.